OWA
JAZZ icon

One Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

One Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Sell
1,229
-348
-22% -$76.2K 0.03% 267
2026
Q1 		$298K Sell
1,577
-661
-30% -$116K 0.04% 245
2025
Q4 		$380K Buy
2,238
+3
+0.1% +$460 0.05% 204
2025
Q3 		$295K Buy
+2,235
New +$268K 0.04% 237

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

One Wealth Advisors's JAZZ Position: Q2 2026 in Review

One Wealth Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 22% in Q2 2026, selling an estimated $76.2K and leaving 1,229 shares worth $296K. The position accounts for 0.03% of the portfolio, ranked #267.

One Wealth Advisors first reported a position in JAZZ in Q3 2025 and has held it in 4 quarters since. The position peaked at $380K in Q4 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • One Wealth Advisors held 1,229 shares of Jazz Pharmaceuticals worth $296K as of Q2 2026.
  • One Wealth Advisors sold 348 Jazz Pharmaceuticals shares in Q2 2026, an estimated $76.2K.
  • Jazz Pharmaceuticals made up 0.03% of One Wealth Advisors's portfolio in Q2 2026, its #267 holding.
  • One Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • One Wealth Advisors's Jazz Pharmaceuticals position peaked at $380K in Q4 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on One Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.